title: No evidence for persistence of BCR-ABL-positive cells in patients in molecular remission after conventional allogenic transplantation for chronic myeloid leukemia.
authors.forename: M
authors.initials: M
authors.lastname: Deininger
authors.forename: T
authors.initials: T
authors.lastname: Lehmann
authors.forename: R
authors.initials: R
authors.lastname: Krahl
authors.forename: E
authors.initials: E
authors.lastname: Hennig
authors.forename: C
authors.initials: C
authors.lastname: Müller
authors.forename: D
authors.initials: D
authors.lastname: Niederwieser
mesh_terms: D001773:Blood Cells / Q000737:chemistry*; D005260:Female; D016044:Fusion Proteins, bcr-abl / Q000097:blood* / Q000235:genetics; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000097:blood / Q000601:surgery*; D008297:Male; D012074:Remission Induction; D014184:Transplantation, Homologous
chemical_list: D016044:Fusion Proteins, bcr-abl